|
🐜
|
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
106 auth.
F. Visseren,
F. Mach,
Y. Smulders,
D. Carballo,
K. Koskinas,
Maria Bäck,
A. Benetos,
A. Biffi,
J. Boavida,
D. Capodanno,
B. Cosyns,
Carolyn B Crawford,
C. Davos,
I. Desormais,
E. Angelantonio,
...
O. Franco,
S. Halvorsen,
F. R. Hobbs,
M. Hollander,
E. Jankowska,
M. Michal,
Simona Sacco,
N. Sattar,
L. Tokgozoglu,
S. Tonstad,
K. Tsioufis,
I. V. Dis,
I. C. Gelder,
C. Wanner,
B. Williams,
G. D. Backer,
V. Regitz-Zagrosek,
A. Aamodt,
M. Abdelhamid,
V. Aboyans,
C. Albus,
R. Asteggiano,
Magnus Bäck,
M. Borger,
C. Brotons,
J. Čelutkienė,
R. Cífková,
M. Čikeš,
F. Cosentino,
N. Dagres,
T. D. Backer,
D. Bacquer,
V. Delgado,
H. Ruijter,
P. Dendale,
H. Drexel,
V. Falk,
L. Fauchier,
B. Ference,
J. Ferrières,
M. Ferrini,
M. Fisher,
D. Fliser,
Z. Fras,
D. Gaita,
S. Giampaoli,
S. Gielen,
I. Graham,
C. Jennings,
T. Jørgensen,
A. Kautzky-Willer,
M. Kavousi,
W. Koenig,
A. Konradi,
D. Kotecha,
U. Landmesser,
Madalena Lettino,
B. Lewis,
A. Linhart,
M. Løchen,
K. Makrilakis,
G. Mancia,
P. Marques-Vidal,
J. McEvoy,
Paul McGreavy,
B. Merkely,
L. Neubeck,
J. Nielsen,
J. Perk,
Steffen E Petersen,
A. Petronio,
M. Piepoli,
N. Pogosova,
E. Prescott,
K. Ray,
Ž. Reiner,
D. Richter,
L. Rydén,
E. Shlyakhto,
M. Sitges,
M. Sousa‐Uva,
I. Sudano,
M. Tiberi,
R. Touyz,
A. Ungar,
W. Verschuren,
O. Wiklund,
D. Wood,
J. Zamorano,
Carolyn A Crawford,
Oscar Durán
|
11 |
2021 |
11
🐜
|
|
🦁
|
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
24 auth.
F. Cosentino,
P. Grant,
V. Aboyans,
Clifford J. Bailey,
A. Ceriello,
V. Delgado,
M. Federici,
G. Filippatos,
D. Grobbee,
T. Hansen,
...
H. Huikuri,
I. Johansson,
P. Jüni,
M. Lettino,
N. Marx,
L. Mellbin,
C. Östgren,
B. Rocca,
M. Roffi,
N. Sattar,
P. Seferovic,
M. Sousa‐Uva,
P. Valensi,
D. Wheeler
|
11 |
2019 |
11
🦁
|
|
🐢
|
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
F. Paneni,
J. Beckman,
M. Creager,
F. Cosentino
|
10 |
2013 |
10
🐢
|
|
🐢
|
The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
P. Grant,
F. Cosentino
|
10 |
2019 |
10
🐢
|
|
🐬
|
Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I
M. Creager,
T. F. Lüscher,
F. Cosentino,
J. Beckman
|
9 |
2003 |
9
🐬
|
|
🐜
|
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.
15 auth.
C. Cannon,
R. Pratley,
S. Dagogo-Jack,
J. Mancuso,
S. Huyck,
Urszula Masiukiewicz,
B. Charbonnel,
R. Frederich,
Silvina Gallo,
F. Cosentino,
...
W. Shih,
I. Gantz,
S. Terra,
D. Cherney,
Darren K Mcguire
|
9 |
2020 |
9
🐜
|
|
🦁
|
High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells.
F. Cosentino,
K. Hishikawa,
Z. Katusic,
T. Lüscher
|
9 |
1997 |
9
🦁
|
|
🐜
|
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
14 auth.
D. McGuire,
W. Shih,
F. Cosentino,
B. Charbonnel,
D. Cherney,
S. Dagogo-Jack,
R. Pratley,
Michelle Greenberg,
Shuai Wang,
S. Huyck,
...
I. Gantz,
S. Terra,
Urszula Masiukiewicz,
C. Cannon
|
9 |
2020 |
9
🐜
|
|
🐜
|
The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society.
27 auth.
C. Vlachopoulos,
P. Xaplanteris,
V. Aboyans,
M. Brodmann,
R. Cífková,
F. Cosentino,
M. De Carlo,
A. Gallino,
U. Landmesser,
S. Laurent,
J. Lekakis,
D. Mikhailidis,
K. Naka,
A. Protogerou,
D. Rizzoni,
...
A. Schmidt-Trucksäss,
L. V. Van Bortel,
T. Weber,
A. Yamashina,
R. Zimlichman,,
P. Boutouyrie,
J. Cockcroft,
M. O'Rourke,
J. Park,
G. Schillaci,
H. Sillesen,
R. Townsend
|
9 |
2015 |
9
🐜
|
|
🐜
|
Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.
8 auth.
E. Stroes,
J. Kastelein,
F. Cosentino,
W. Erkelens,
Ron Wever,
Hendrik A. Koomans,
...
T. Lüscher,
T. Rabelink
|
9 |
1997 |
9
🐜
|
|
🐬
|
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II.
J. Beckman,
F. Paneni,
F. Cosentino,
M. Creager
|
9 |
2013 |
9
🐬
|
|
🐜
|
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
33 auth.
P. Seferovic,
M. Petrie,
G. Filippatos,
S. Anker,
G. Rosano,
J. Bauersachs,
W. Paulus,
M. Komajda,
F. Cosentino,
Rudolf A. de Boer,
D. Farmakis,
W. Doehner,
E. Lambrinou,
Y. Lopatin,
M. Piepoli,
...
M. Theodorakis,
H. Wiggers,
J. Lekakis,
A. Mebazaa,
M. Mamas,
C. Tschöpe,
A. Hoes,
J. Seferovic,
J. Logue,
T. McDonagh,
J. Riley,
Ivan Milinković,
M. Polovina,
D. V. van Veldhuisen,
M. Lainščak,
A. Maggioni,
F. Ruschitzka,
J. McMurray
|
9 |
2018 |
9
🐜
|
|
🦁
|
High Glucose Causes Upregulation of Cyclooxygenase-2 and Alters Prostanoid Profile in Human Endothelial Cells: Role of Protein Kinase C and Reactive Oxygen Species
11 auth.
F. Cosentino,
M. Eto,
P. de Paolis,
B. van der Loo,
M. Bachschmid,
V. Ullrich,
...
A. Kouroedov,
C. Gatti,
H. Joch,
M. Volpe,
T. Lüscher
|
8 |
2003 |
8
🦁
|
